GLAUKOS Corp

GKOS · XNYS

CIK 1192448fmd_1XYF14ZCTQ21CJB8J7CATZ3ANMManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	114	159	181	237	225	294	283	315	383	507
Cost of revenue	16	21	25	39	92	67	69	76	94	112
Gross profit	98	138	156	198	133	227	214	239	289	283
Research and development	29	39	50	68	85	101	123	139	136	151
Selling, general and administrative	65	96	120	177	171	179	193	224	261	332
Total operating expenses	94	140	169	249	257	260	296	368	412	482
Operating income	4	(2)	(13)	(50)	(124)	(33)	(82)	(129)	(122)	(200)
Interest expense	–	–	–	3	14	13	14	14	10	5
Interest and investment income	1	1	2	3	2	1	2	9	11	11
Other non-operating income (expense)	0	2	1	0	(9)	(16)	(16)	(5)	(23)	7
Income before taxes	5	0	(12)	(50)	(132)	(49)	(98)	(134)	(146)	(193)
Income tax expense	0	0	1	(65)	(12)	0	1	1	1	(5)
Net income from continuing operations	5	(0)	(13)	15	(120)	(50)	(99)	(135)	(146)	(188)
Net income	5	(0)	(13)	15	(120)	(50)	(99)	(135)	(146)	(188)